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Motivation

Gene expression studies are swiftly becoming a very significant and prevalent
tool in biomedical research. The microarray and gene-chip technologies allow
researchers to monitor the expression of thousands of genes simultaneously. A
typical experiment results in an observed data matrix X whose columns are
n copies of a p-dimensional vector of gene expression measurements, where
n is the number of observations and p is the number of genes. Consider, for
example, a population of cancer patients from which we take a random sample
of n patients, each of whom contributes p gene expression measurements. For
microarrays, each measurement is a ratio, calculated from the intensities of
two flourescently labeled mRNA samples cohybridized to arrays spotted with
known cDNA sequences. Gene chips produce similar data, except each element
is a quantitative expression level rather than a ratio. Data preprossessing
may include background subtraction, combining data from replicated spots
representing the same cDNA sequence, normalization, log transformation, and
truncation.
Given data from such an experiment, researchers are interested in identifying
groups of differentially expressed genes which are significantly correlated with
each other, since such genes might be part of the same causal mechanism or
pathway. For example, healthy and cancerous cells can be compared within
subjects in order to learn which genes tend to be differentially expressed together in the diseased cells; regulation of such genes could produce effective
cancer treatment and/or prophylaxis [4,5,12,14]. In addition to identifying
interesting clusters of genes, researchers often want to find subgroups of samples which share a common gene expression profile. Examples of such studies
include classifying sixty human cancer cell lines [16], distinguishing two different human acute leukemias [9], dissecting and classifying breast cancer tumors
[15], and classifying sub-types of B-cell lymphoma [1] and cutaneous malignant
melanoma [2].
Most gene expression research to date has focused on either the gene problem
or the sample problem, or possibly on the two problems as separate tasks.
Many researchers have performed two-way clustering by applying algorithms
to both genes and samples separately and possibly reordering the rows and
columns of the data matrix according to the clustering results. Tibshirani et
al. [17], for example, illustrate several methods for two-way visualization of a
reordered data matrix based on separately clustering genes and samples. They
also propose applications of block clustering and principal components analysis
to simultaneously cluster genes and samples. Their gene shaving methodology
addresses the problem that different subsets of genes might cluster samples in
different ways.
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We want to emphasize the importance of this last issue. Consider, for example, that different gene clusters represent different biological mechanisms or
states, so that there may be clusters of genes which are very good for distinguishing different types of samples. In addition to an overall clustering label,
sub-groups of samples could be more accurately characterized by their expression pattern for each of these gene clusters. In this way, we might find
that in an experiment consisting of three types of cancer, several gene clusters show similar expression across all three types (generic cancer genes), one
gene cluster shows two types of cancer clustering together, and another gene
cluster shows a different two types of cancer clustering together. It is possible
that clustering the samples using all genes might not have revealed the three
types of cancer, whereas the characterization based on the patient clustering
within separate gene clusters would make the distinction clear. Similarly, first
clustering samples and then genes within sample clusters could offer more insight than simply clustering genes. For example, in a heterogeneous sample
of patients, clustering patterns seen in individual patient groups might disappear when averaged across groups or the profile of the more numerous patient
group might dominate. Concern over failing to identify these more subtle and
complicated patterns in gene expression data has motivated the development
of a general statistical framework for simultaneous clustering.
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Background

Approaches to gene expression data analysis rely heavily on results from
cluster analysis (e.g.: k-means, self-organizing maps and trees), supervised
learning(e.g.: recursive partitioning), and classification and regression trees
(CART). We recommend the clustering algorithm Partitioning Around Medoids
(PAM) [11], because it is nonparametric and more robust to outliers than
many other methods. PAM takes a dissimilarity matrix (based on any distance metric of interest) as input. For a given number of clusters K, PAM
selects K potential medoids from the observed data, identifies for all other
elements the distance to the closest of these potential medoids, and minimizes
over the vector of K potential medoids the sum of these distances over all elements. The solution to this minimization problem is the vector of K medoids,
each identifying a cluster defined as those elements which are closer to that
medoid than to any of the other K − 1 medoids. Because of how they are
selected, the medoids are more stable than the mean vectors in k-means. The
statistical framework we present can be applied with any choice of clustering
algorithm, but we will use PAM to illustrate the methodology because of its
nice properties.
All exploratory techniques are capable of identifying interesting patterns in
data, but they do not inherently lend themselves to statistical inference. It is
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necessary to define important statistical notions such as parameter, parameter
estimate, consistency, and confidence. The ability to assess reliability in an
experiment is particularly crucial with the high dimensional data structures
and relatively small samples presented by gene-expression experiments. In the
biotechnology industry, for example, where thousands of potential drug targets
are screened simultaneously, it is imperative to have a method to determine
the significance of gene clusters found in a single microarray experiment.
Others have noted this need for statistical rigor in gene expression data analysis [10,13]. Van der Laan and Bryan [18], present a general statistical framework for clustering genes using a deterministic subset rule applied to (µ, Σ),
the mean and covariance of the gene expression distribution. A typical subset rule will draw on “screens” and “labellers”. A screen is used to eliminate
certain genes from the subset. A labeller will apply labels, such as the output
of a clustering routine. Meaningful analyses can be done with various combinations of screens and labellers or even with a screen or labeller alone. For
example, one might apply PAM to all genes at least two-fold differentially expressed. The target subset S(µ, Σ) is the subset (with cluster labels) the subset
rule would select if the true data generating distribution were known, and it
is estimated by the observed sample subset S(µ̂n , Σ̂n ), where the empirical
mean and covariance are substituted for the true parameters. Most currently
employed clustering methods fit into this framework, since they need only
be deterministic functions of the empirical mean and covariance µ̂n , Σ̂n . The
authors also provide measures and graphs of gene cluster stability based on
the parametric bootstrap using a truncated multivariate normal distribution
n
→ ∞ of:
N (µ̂n , Σ̂n ). Finally, they establish consistency under log(p)
(1) µ̂n , Σ̂n and hence smooth functions S(µ̂n , Σ̂n ).
√
(2) the parametric bootstrap for the limiting distribution of n(µ̂n − µ, Σ̂n −
Σ) and simple convergence of the bootstrap subset to the true subset.

3

Simultaneous Clustering Parameter

In this paper we propose a generalization of the method of van der Laan
and Bryan [18] such that the subset rule may include a multi-stage clustering
method which involves simultaneous clustering of genes and samples. In order
to be concrete, we will refer to the samples as patients, but the methodology applies to any i.i.d. experimental units. Define a simultaneous clustering
parameter as a function of the true data generating distribution which is
a composition of a mapping involving clustering of patients and a mapping
involving clustering of genes. An estimate of the simultaneous clustering parameter is obtained by applying this function to the empirical distribution.
This formal framework allows us to assess classical properties of the clustering
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method such as consistency (in the novel context of n << p) and also allows
us to study statistical inference regarding the clustering parameter.

3.1

Clustering Patients

Given k1 and an m-variate distribution P , let Φ1 (P ) = (Pj (P ), pj (P ) : j =
1, . . . , k1 ) be an algorithm that maps P into k1 m-variate distributions P1 , . . . , Pk1
and corresponding mixing proportions p1 , . . . , pk1 . This mapping Φ1 (P ) represents clustering of patients.
For example, one could fit to P a mixture of k1 m-variate normal distributions.
In other words, let f (x | (µj , Σj , pj ), j = 1, . . . , k1 ) be the density of a mixP
ture j pj N (µj , Σj ) of kR1 multivariate normal distributions. Now, we could
define Φ1 (P ) = max−1 log(f (X | (µj , Σj , pj ), j = 1, . . . , k1 ))dP (x) as the
distribution (i.e.: parameters) which maximizes the log-likelihood, where the
maximum is taken over all mixtures of multivariate normal distributions. In
this case, the algorithm involves maximum likelihood estimation over a mixture of parametric families, which could be carried out with the EM-algorithm.
This clustering methodology is carried out by Fraley and Raftery [7], and it
is referred to as model based clustering.
The alternative to model based clustering is nonparametric clustering which is
much less computer intensive. One particular method of nonparametric clustering is PAM. In this case, the easiest way to define Φ1 (P ) is by simulation.
In other words,
(1) sample an infinitely large number (say N ) observations from P ,
(2) compute a N × N -distance matrix containing the pairwise distances for
each pair of observations for some specified distance metric,
(3) apply the clustering algorithm PAM to split the N observations into k1
groups,
(4) for each group j, report the proportions of observations pj and the empirical cumulative distribution function Pj of these observations, j =
1, . . . , k1 .
If N = ∞, then the output of this simulation algorithm is a function Φ1 (P ) =
(Pj , pj : j = 1, . . . , k1 ).

3.2 Clustering Genes

Given k2 and an m-variate distribution Q, let Φ2 (Q) = (mj (Q), Sj (Q), Gj (Q) :
j = 1, . . . , k2 ) be an algorithm that maps Q into k2 mj (Q)-variate subdistribu4

tions G1 (Q), . . . , Gk2 (Q) of Q corresponding with subsets Sj (Q) of {1, . . . , m}
of sizes mj . This algorithm represents the clustering of m genes into k2 clusters
Sj of genes of sizes mj , j = 1, . . . , k2 . We might also extend the definition of
Sj so that it includes not just the clusters, but also other output of a clustering algorithm such as probabilities that genes belong to a cluster (fuzzy
membership).
As highlighted in van der Laan and Bryan [18], the finding of the actual
clusters sj (Q) of genes, j = 1, . . . , k2 , can typically be based on the m-variate
mean vector µ(Q) and the m × m-covariance matrix Σ(Q) of Q. In that case,
sj (Q) = sj (µ(Q), Σ(Q)), j = 1, . . . , k2 . For example, Φ2 (Q) can be defined by
applying PAM to a m × m-distance matrix (Euclidean, correlation, absolute
correlation, etc.) calculated from the m × m-covariance matrix Σ(Q).

3.3

Compositions

To summarize we have:
Φ1 (P ) = (pj (P ), Pj (P ) : j = 1, . . . , k1 )
Φ2 (Q) = (mj (Q), Sj (Q), Gj (Q) : j = 1, . . . , k2 ),
where Φ1 and Φ2 are defined by what algorithm you want to use (e.g.: clustering with a specified distance metric). Note that Φ1 splits the population
into k1 subpopulations so that applied to patients it will split the sample into
k1 subsamples, while Φ2 splits the dimension into subdimensions. These mappings Φ1 (P ) and Φ2 (Q), representing clustering of patients and genes, are the
building blocks for simultaneous clustering parameters Φ(P ).
Define the composition Φ2 ◦ Φ1 (P ) as a k1 × k2 -matrix with (I, J)-th element being (pI (P ), PI (P ), mJ (PI (P )), SJ (PI (P )), GJ (PI (P ))), i.e. it reports
the I-subpopulation distribution of patients computed by Φ1 (P ) and the corresponding J-th cluster of genes. Similarly, define the composition Φ1 ◦Φ2 (P ) as a
k2 ×k1 -matrix with (I, J)-element being (mI (P ), SI (P ), GI (P ), pJ (GI (P )), PJ (GI (P ))),
i.e. it reports the I-th cluster of genes and clusters patients just based on the
genes in this I-th cluster. Then, Φ2 ◦ Φ1 (P ) represents clustering genes within
each cluster of patients and Φ1 ◦ Φ2 (P ) represents clustering patients within
each cluster of genes. Stopping at this stage often reveals interesting patterns
in the data.
One might find it of interest to iterate these compositions in order to design
more “aggressive” algorithms. The mappings can be composed alternately. For
example, one might 1) cluster genes, 2) within each cluster of genes cluster
patients, and 3) within each cluster of patients cluster genes again. The result5

ing simultaneous clustering parameter Φ2 ◦ Φ1 ◦ Φ2 (P ) reports the I-th cluster
of genes based on all patient data, the J-th cluster of patients just based on
I-th cluster of genes and the K-th cluster of genes just based on this J-th
cluster of patients. It is natural to think of such a multi-way-array as a tree
which is many levels deep so that to get to the (I, J, K)-th element of the tree,
for example, one goes to branch I at the first node, branch J at the second
node and branch K at the third node. One could also iterate one mapping
repeatedly. Define
(1) Φ1 ◦ Φ1 (P ) as a k1 × k1 -matrix with (I, J)-th element being
(pI (P ), PI (P ), pJ (PI (P )), PJ (PI (P ))),
i.e. it reports the I-th cluster of patients based on all data and the J-th
cluster of patients just based on this I-th cluster of patients.
(2) Φ2 ◦ Φ2 (P ) as a k2 × k2 -matrix With (I, J)-th element being
(mI (P ), SI (P ), GI (P ), mJ (GI (P )), SJ (GI (P )), GJ (GI (P ))),
i.e. it reports the I-th cluster of genes based on all data and the J-th
cluster of genes just based on this I-th cluster of genes.
Thus, clustering of samples (or genes) is defined within an earlier obtained
cluster of samples (or genes). This is top-down (or divisive) hierarchical clustering. It is easy to see that repeatedly applying Φ1 or Φ2 results a final hierarchical tree structure of the type produced by Eisen’s application of bottom-up
(agglomerative) hierarchical clustering [6]. Note that contrary to his algorithm,
we are not necessarily restricted to binary splits, making this approach more
general. The block clustering method for gene expression data described in
Tibshirani et al. [17] can also be expressed as a hierarchical iteration which
includes both Φ1 and Φ2 . It is important to remember that applying such iterated algorithms to the actual data yields very aggressive search algorithms.
We must keep in mind that as more compositions are taken, the mapping
becomes less smooth so that there is a trade off between stability (i.e.: sample
size needed) and an aggressive search (i.e.: finding patterns in the data).
Now, we can define a simultaneous clustering parameter θ = Φ(P ) as some
(possibly iterative) composition of Φ1 , Φ2 .

3.4

Summary Measures of the Simultaneous Clustering Parameter

It is useful to consider various summary measures of the simultaneous clustering parameter θ. Examples of such summary measures include:
6

• Cluster Membership (Genes only): probabilities (fuzzy clustering), assignments (hard clustering). Recall that patient cluster labels are not a
parameter.
• Cluster Size: proportion in each cluster
• Cluster Profile: means, medoids, indicator that a gene cluster shows
strong differential expression (uniform) in at least one of the patient clusters.
• Cluster Strength: diameter, separation, silhouettes, measures of how uniformly the genes behave across patients.
Many of these measures can be summarized together in a picture. For example,
we can order the gene clusters within each cluster of patients, and then order
patients and genes within clusters. Ordering can be based on distance between
clusters, silhouette, or some dimension reducing projection (multidimensional
scaling, principal components). For each cluster of patients, we might visualize
(i) the reordered data matrix and (ii) the reordered gene-by-gene correlation
(or more generally distance) matrix.

3.5

Estimation and Remarks Regarding Asymptotic Consistency

Let Pn be the empirical distribution of the data. We estimate θ = Φ(P ) with
θn = Φ(Pn ). Note that this is a nonparametric estimate since it is not based
on model assumptions. In particular, if Φ : (D1 , k · k1 ) → (D1 , k · k2 ) is
continuous w.r.t to a metric k · k for which k Pn − P k→ 0 in probability and
p is fixed, then k θn − θ k1 → 0 in probability.
Since, in practice, the number of genes being studied p continues to grow and
to grow much more rapidly than sample size n, it is of interest to establish
consistency of summary measures of θn in the context that the number of genes
p = p(n) increases with n such that n → ∞ and n/ log(p(n)) → ∞. In general,
simultaneous clustering parameters will be much less smooth than S(µ, Σ)
from van der Laan and Bryan [16], and thus consistency, sample size and
asymptotic validity of the bootstrap are issues we need to address. One benefit
of having a composition is that we only need consistency of each mapping
alone in order to show consistency of their composition. Since we already have
consistency for gene clustering, it remains to look at patient clustering.
In this section, we will explain why in principal under appropriate regularity
conditions we can extend the consistency and sample size proofs of van der
Laan and Bryan [16] to the simultaneous clustering context. Let θj = θj (P )
be a real valued parameter of the data generating distribution P of the pdimensional gene expression profiles X, where j indexes a large set of such
parameters, say j = 1, . . . , r(p). Here r(p) is monotone function with bounded
derivative in the number of genes p. In particular, we can view θj as one of
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the many parameters of a simultaneous clustering Φ(P ) = Φ1 ◦ Φ2 (P ). For a
fixed number of genes p and increasing sample size n one will typically have
that the empirical estimate θjn = θj (Pn ) is asymptotically linear:
n
1X
θjn − θj =
ICj (Xi ) + rjn ,
n i=1

√
where | rjn |= oP (1/ n). Here Y → ICj (X) is the influence curve of the
estimator θjn and E{ICj (X)} = 0. Let σj2 = VARICj (X) denote the variance
of the influence curve ICj (X).
Now we can state conditions under which the parameters θjn are uniformly
consistent in j, even in the realistic setting where the arrays keep getting larger
and larger. Let’s now assume that (1) the log gene expressions are truncated,
so that they are bounded from above by a universal constant M , (2) the
influence curves ICj are uniformly bounded√in all possible X’s by a universal
constant C, and (3) the second order term nrjn converges to zero uniformly
in j in probability. Condition 3 requires typically the same assumptions as
condition 2. In other words, once one makes sure that denominators in the
influence curve of the estimator θjn are uniformly bounded away from zero,
one will often also be able to prove a uniform bound on the second order
terms.
Let θ̃jn ≡ θj + n1 i ICj (Xi ) be the first order approximation of θjn . In van
der Laan and Bryan [16] it is shown that if the number of genes p = p(n) is
such that n/ log(p(n)) → ∞ as n → ∞, then, as n → ∞,
P

max |θ̃jn − θj | → 0 in probability,
j

so that, by condition 3,
max |θjn − θj | → 0 in probability.
j

The same Bernstein’s Inequality argument as used in van der Laan and Bryan
[16] leads to a sample size formula based on the first order approximation θ̃jn
of θjn in the more concrete setting of a fixed value of the number of genes p.
Define n∗ with the following formula:
1
2
n∗ (p, , δ, C, σ 2 ) = (log p + log ),
c
δ
where c = c(, σ 2 , C) =

2
.
2σ 2 +2C/3

In the above, σ 2 = maxj σj2 and δ is a
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user-specified value between 0 and 1 that can be thought of as 1 minus the
“power”. If n > n∗ , then




P max |θ̃jn − θj | >  < δ.
j

It is of interest to see that the effect of the number of genes on this sample size
formula (and the truly needed sample size) is very minimal; in other words,
if one needs a certain sample size for 10 genes, then adding 50 subjects to
the sample will guarantee the same uniform precision based on 100000 genes.
This teaches us that achievable sample sizes will allow complete trust in each
of the elements of the observed estimates θjn , which will become essential if
one is interested in selecting association pathways between genes.

4

Statistical Inference with the Bootstrap

Though θ = Φ(P ) generates a large set of methods for finding clustering
patterns in the true data-generating distribution, once applied to empirical
data Pn , it is likely to find patterns due to noise. To deal with this issue, one
needs methods for assessing the variability of θn and, in particular, assessing
the variability of the important summary measures of θn . One also needs to
be able to test if certain components of θn are significantly different from the
value of these components in a specified null-experiment.
To assess the variability of the estimator θn we propose to use the bootstrap.
The idea of the bootstrap method is to estimate the true data generating
distribution P with some estimate Pn and estimate the distribution of θn
#
with the distribution of θn# = Φ(P#
n ), where Pn is the empirical distribution
based on an i.i.d. bootstrap sample (i.e.: a sample of n i.i.d. observations from
Pn ). The distribution of θn# is obtained by applying θ = Φ(·) to P#
n from
each of B bootstrap samples, keeping track of parameters of interest. The
distribution of a parameter is approximated by its empirical distribution over
the B samples.
There are several common methods for generating bootstrap samples.
• Nonparametric: Resample n columns from X with replacement.
• Parametric: Fit a model (e.g.: multivariate normal, mixture of multivariate
normals) and generate observations from the fitted distribution.
• Convex pseudo-data: For d ∈ {0, 0.5}, choose  ∈ {0, d}. Then use  to
form new samples as convex combinations of pairs of randomly sampled
columns of X. This is a smoothed version of the nonparametric bootstrap
proposed by Breiman [3].
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The nonparametric bootstrap has the advantage of being computationally
much easier than the parametric bootstrap. In addition, the nonparametric
bootstrap avoids distributional assumptions √
about the parameter of interest,
whereas the estimation of the distribution of n(Σn −Σ) using the parametric
bootstrap is only consistent under the model assumption. There is reason to
believe, however, that the parametric bootstrap might perform better in the
gene-expression context (where the number of observations n is typically very
small relative to the dimension p), because the empirical distribution Pn (i.e.
nonparametric bootstrap) might be an inappropriate estimate of P .

5

Simulations to Assess the Bootstrap

The performance of the bootstrap is measured by how well the distribution
of θn# approximates the distribution of θn . It is clear that this performance is
mainly dependent on how close Pn is to P . Our initial feeling was that in this
setting, the empirical distribution Pn (i.e. nonparametric bootstrap) might be
an inappropriate estimate of P . There is reason to believe, that the parametric bootstrap might perform better in the gene-expression context, where the
number of observations n is typically very small relative to the dimension p
(number of genes). Another fact of interest is that the nonparametric bootstrap is known to be inconsistent in various low-dimensional examples, while
the parametric bootstrap is consistent under minimal additional assumptions
given that the parametric model is correct [8]. The nonparametric bootstrap
has the advantage, however, of being computationally much easier than the
parametric bootstrap. In addition, the nonparametric bootstrap avoids distributional assumptions about
√ the parameter of interest, whereas the estimation
of the distribution of n(Σn − Σ) using the parametric bootstrap is only
consistent under the model assumption.
With these ideas in mind, we conducted a set of simulation studies to assess
the asymptotic validity of the nonparametric, convex, and parametric bootstraps for estimating the distribution of a simultaneous clustering parameter.
Since θ can take many forms but is always a composition of the mappings Φ1
and Φ2 , we designed the simulations to look at Φ1 and Φ2 separately. In all of
the simulations, we used p = 3000 genes and n = 40 samples. These choices
reflect typical dimensions of the data matrix X (possibly after prescreening)
as seen in commercial and academic settings. In order to investigate the effect
of asymptotics on our results, we repeated all the simulations using n = 250
samples. We also repeated the Simulation 2 with n = 150 samples and p = 12
genes in order to look at the relative dependence of the asymptotics of patient
clustering on the number of genes and the number of samples. All simulations and data analyses were carried out on a Dell Precision Workstation 620
with dual 1GHz processors and 2G of RAM using the statistical programming
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languages R and Splus.

5.1

Simulation 1: Multivariate Normal Data (with diagonal covariance)

Simulation 1 investigates Φ2 for gene clustering. The true data generating
distribution was chosen to be a multivariate normal with diagonal covariance
matrix so that the genes were uncorrelated. For simplicity, a fourth of the
genes was generated from each of four distributions: N (0.5, 0.25), N (−0.5, 0.5),
N (1, 1), N (−1, 0.75). The summary measures of interest were selected to be
the 0.9 quantile of the maximum absolute difference in the mean vector, median vector, and correlation matrix. These measures give a good indication of
how far a distribution is from the truth.
In order to define the “true” values of the summary measures, a large number
N draws from the true distribution were compared to the known mean, median
and correlation. Results were compared for N = 100, 1000, 10000 and showed
little dependence on N so that N = 100 was deemed sufficient. Next, a single
draw from the true distribution was identified as the ”observed” data and
the three types of bootstrap were performed with convex repeated for d =
0.1, 0.3, 0.5. In each case, B = 100 bootstrap samples were generated from
which the 0.9 quantiles were calculated. In order to investigate the variability
of these measures, we repeated each simulation twenty times with n = 40
samples and p = 3000 genes, obtaining twenty sets of 0.9 quantiles. From these,
we calculated a mean and standard deviation. The coefficient of variation was
on the order of 2.5% for the mean, 3.0% for the median and 1.25% for the
correlation. These values were sufficiently small that we chose to use the results
from just one simulation of B = 100 bootstrap samples in each case.
Table 1 shows the results of Simulation 1. We found that the bootstrap is
good at n = 250 and a little conservative at n = 40. At both sample sizes, the
bootstrap performed poorly for the median, which is a known result. It is interesting to note that in contrast to our hypothesis, the nonparametric bootstrap
actually performed well relative to the convex and parametric bootstrap. We
had expected the convex bootstrap, a smoothed version of the nonparametric,
to perform consistently better than the nonparametric. Instead, we found that
the convex was more biased for the mean than the nonparametric, performing
best when d was smallest (d = 0 is equivalent to nonparametric).
This simulation suggests that the nonparametric and parametric bootstraps
can be used to assess the variability of summary measures of gene clustering
(see also van der Laan and Bryan [18]). Since estimated variability in the means
is quite accurate and estimated variability in the correlation is accurate at n =
250 and conservative at n = 40, then we should be able to assess the variability
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of subset rules of the form S(µ, Σ) accurately (or at least conservatively) for
reasonable sample sizes.

5.2

Simulation 2: Mixture of 2 Multivariate Normals (with diagonal covariance)

Simulation 2 investigates Φ1 for patient clustering. The true data generating
distribution was chosen to be a mixture of two multivariate normals with
identical, diagonal covariance matrices so that the genes were uncorrelated.
The difference between the two component distributions in the mixture, then,
was due solely to the difference in their mean vectors. Again, a fourth of the
genes for each component distribution had one of four means, so that
(µ1 , µ2 ) ∈ {(0.5, −0.5), (0.25, −0.25), (−0.5, 0.5), (−0.25, 0.25)}.
All variances were 2 and the mixing proportion was q = 0.3. Data was simulated from a mixture such as this by first selecting one of the two component
distributions (with probability q of choosing the first) and then drawing a
sample from that distribution. The parameter values for this simulation were
selected so that there was sufficient overlap between the two component distributions in the mixture to occasionally confuse a clustering algorithm attempting to identify the source distribution of a randomly drawn sample.
The “true” values of summary measures were determined by comparing N =
100 draws from the true distribution to the mean value across the N samples.
Next, a single draw from the true distribution was identified as the “observed”
data and the three types of bootstrap were performed. In each case, B =
100 bootstrap samples were generated from which summary measures were
computed in the same way.
In contrast to the gene clustering problem, where all genes appear in every
sampled vector in a bootstrap sample, the original subjects are not all represented in a bootstrap sample. Indeed, in the convex bootstrap samples are now
weighted averages over pairs of subjects, and in the parametric bootstrap all
correspondence with original subjects is lost. We can not consider summary
measures of θ that involve subject labels, since these are not parameters. We
can, however, keep track of summary measures which pertain to clusters of
subjects. These summary measures can be separated into those which depend
on the cluster label (e.g.: cluster medoids or mean vectors) and those which
do not (e.g.: features of the smallest cluster, differences between clusters). The
former type of output requires supervised clustering. A supervised clustering
procedure is one in which known clusters (e.g.: those found in the “observed”
data set) are reused so that the subjects in each bootstrap sample are as12

signed to the closest of these clusters. An unsupervised clustering procedure
allows new clusters to be identified in each bootstrap sample. We applied both
supervised and unsupervised clustering as outlined below.
Supervised Clustering:
• For each subject in a bootstrap sample, compute the distance to each of the
known mean vectors.
• Assign that subject to the closest cluster.
• Examples of summary measures: mixing proportion, cluster means.
Unsupervised Clustering:
• Apply the PAM algorithm (k = 2) to each bootstrap sample.
• The clusters do not necessarily correspond to the original clusters.
• Examples of summary measures: distance between medoids, diameter of the
smaller cluster, average silhouette.
In a nonparametric unsupervised bootstrap, the cluster medoids will most
likely be different from those from the original sample, and in a convex or
parametric unsupervised bootstrap, the medoids can not be identical to those
from the original sample. There are nonetheless several ways to infer a correspondence between the bootstrap and original clusters. If the clusters differ
greatly in size and are well separated, as in the data analysis section, we
may be able to infer a correspondence directly. Otherwise, we could order
the clusters from the bootstrap sample with respect to distance relative to the
original cluster medoids. Each bootstrap cluster would then “correspond” with
the closest original medoid. In the case of a tie, the closer bootstrap cluster
could be assigned to the original medoid and the other bootstrap cluster to
the medoid next closest to it. Another approach to inferring a correspondence
between each set of bootstrap clusters and the original clusters, is to align
the clusters by examining the matrix of pair-wise distances between all bootstrap and original clusters and consecutively matching the closest pairs. The
distance between clusters could be based on the distance between medoids
or a measure of the overlap in membership, such as (A ∩ B)/(A ∪ B) or
P (A|B)/2 + P (B|A)/2.
Table 2 shows the results from supervised clustering. For each of the summary
measures, the bootstrap estimates differed from the estimated true values. This
difference was greatest for the convex bootstrap and reduced in magnitude for
all three types of bootstrap with increasing n. These differences could be due
to both bias and variance. In practice, the bootstrap is used to estimate the
variance of an estimate, not its bias. So, we are more interested in whether
the bootstraps correctly estimate this variance than in whether the bootstrap
point estimates of summary measures of θn are biased for fixed n. For example,
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√
the estimated standard errors for q̂ were quite good. Note that we report nσ̂
rather than the standard error of the bootstrap samples (σ̂), since it is the
quantity which should be used to evaluate the asymptotic consistency of the
bootstrap. The bias in the centering of confidence intervals for q̂ and in the
estimated mean vectors (at n = 40 versus n = 250) indicates that for patient
clustering, larger sample sizes might be needed for unbiased point estimates.
The results for n = 150, p = 12 are similar to those for p = 3000, indicating,
as we have seen for gene clustering, that the asymptotics of patient clustering
are driven more by n than by p. When additional genes are drawn from the
same distribution, as in this simulation, having more genes actually provides
more information about this distribution so that the high dimension of gene
expression data might in fact be useful for estimation.

Table 3 shows the results from unsupervised clustering. Again, we see a bias in
the bootstrap point estimates so that the estimated 95% CI’s are not correctly
centered. The parametric bootstrap did quite well, however, at estimating the
width of the CI’s (i.e.: σ̂) even for n = 40. The nonparametric and convex bootstraps were conservative. Results for n = 150, 250 indicate that the
nonparametric and parametric bootstraps are asymptotically valid for estimating the variability of summary measures of patient clustering. As seen in
Simulation 1, the convex bootstrap performed relatively poorly. One possible
explanation, in this case, might be that averaging two subjects characteristic
of each of the component distributions creates a new ”subject” which belongs
equally to each underlying subpopulation and hence is more difficult to cluster.

We noted two interesting facts about the average silhouette. First, we found
that average silhouette is a very stable parameter, which makes sense in light
of the fact that it is an average over many elements. Secondly, we noticed
that the parametric bootstrap may be optimistic about patient clustering.
Consequently, parametric bootstrap confidence intervals for the average silhouette were of correct width but particularly biased (especially at n = 40),
and this bias was in favor of stronger evidence of clustering than was seen in
the observed data. We must remember, however, that since the silhouette is so
stable, its variance is close to zero for relatively small sample sizes. Therefore,
one can not expect that bootstrap confidence intervals will precisely cover the
true confidence intervals. In practice, we would use the observed value for an
estimate and perform the bootstrap only in order to estimate the variance of
this estimate. Averaging across bootstrap samples to obtain a new estimate is
called “bagging” and in this case does not seem to improve estimation.
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5.3

Conclusions

Overall, these simulations indicate that larger sample sizes may be needed
to avoid bias in estimates of the less smooth summary measures of patient
clustering compared to the smoother summary measures of gene clustering.
Nonetheless, the asymptotic validity of the nonparametric and parametric
bootstraps for estimating the variability of these summary measures is clear
in the results for n = 250. This is the true purpose of the bootstrap. Surprisingly, the nonparametric bootstrap performed relatively well compared to
the parametric, although it was very conservative at n = 40 for estimating
the variance of summary measures in the unsupervised clustering simulation.
So, this may be a case where the extra computational effort of the parametric bootstrap would be worthwhile. The convex bootstrap had inconsistent
performance and can not be recommended uniformly as an improvement to
the nonparametric bootstrap. The results for n = 150, p = 12 indicate that
the asymptotics of patient clustering, like gene clustering, are driven by the
number of samples rather than the number of genes.

6

Data Analysis

In order to demonstrate the methodology presented in this paper, we have
applied simultaneous clustering using PAM with a Euclidean distance metric
to the publicly available data set published in Golub et al. [9]. Affymetrix
GeneChips were measured for each of 38 leukemia patients, 27 with acute
myeloid leukemia (AML) and 11 with acute lymphoblastic leukemia (ALL).
Good gene expression data was available for 5925 genes. We truncated the expression measurements below by 100 and above by 16000. For computational
ease, we reduced the dimension of the data set by selecting a subset of 2000
genes with greatest across patient variance. We would not necessarily recommend this prescreening procedure in general, since we have seen in other data
sets that ”interesting” genes (even when the goal is to cluster patients) are
not necessarily always those with highest variance. Since our goal here was to
demonstrate a methodology on a familiar data set, removing some potentially
interesting genes was not so problematic. Prescreening based on expression
level is also of interest and can be easily performed on microarray data, where
the log ratios are centered around zero, by simply choosing a cut off value C
and selecting all genes with absolute mean expression (or a certain proportion
of samples with absolute expression) greater than C. With gene chip data such
as this, the expression measurements span a large range of positive values so
that choosing a cut off value for differential expression is harder. Hence, we
used a variance based prescreen.
15

We proceeded to perform simultaneous clustering on the data set containing
2000 genes, ignoring the ALL/AML labels except to check how well the patient
clusters corresponded with this classification.
6.1

Clustering Genes within Patient Clusters

First, we clustered patients using PAM with a Euclidean distance metric. The
average silhouette is an output of the PAM algorithm which measures cluster
strength. Maximizing the average silhouette is, therefore, one method for selecting the best number of clusters, k, from a range of options. This approach
strongly suggested k = 2, and the resulting cluster labels corresponded very
well with the AML/ALL labels (See Table 4). Next, we clustered genes within
each of the two patient clusters. For both patient clusters, average silhouettes
indicated two gene clusters and were very high for k = 2 (> 0.9). Figure 1 illustrates the results of this simultaneous clustering. The lines marking the cluster
boundaries look sensible. We have reordered the patient and gene clusters and
then the elements within each cluster according to the distance metric, so that
those with similar expression profiles are close to each other. Note that in all
plots the numbering of the genes on the axes refers to the reordering of genes
for that patient cluster, so that a gene may appear in a different place in the
ordering (i.e.: with a different number) for each patient cluster plot.
Within each patient cluster, we found one large cluster containing most genes
and one small cluster containing the very highly expressed genes (plots 1a and
2a in Figure 1). There were 46 genes which made it into in the second cluster
within both patient groups. In addition, there were 8 genes which were placed
in gene cluster 2 within one patient cluster but not the other (6 for patient
cluster 1 and 2 for patient cluster 2). While we would have found most of the
46 common genes and all of the 6 genes unique to patient cluster 1 if we had
simply clustered genes using all patients, the 2 genes unique to patient cluster
2 would have been missed. Furthermore, we would likely not have realized
that the 6 genes unique to patient cluster 1 were more highly expressed in
these patients (mostly ALL) than the other patient group. This result is not
surprising, since patient cluster 1 is more than twice the size of patient cluster
2, and hence its expression pattern could be expected to dominate overall.
Here we have an illustration of the advantage of first clustering patients before
clustering genes.
6.2

Clustering Genes Hierarchically

Another application of simultaneous clustering is to iteratively apply a gene
(or patient) clustering algorithm in a hierarchical manner, so that at each
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level the members of each cluster are themselves clustered. In this way, we
can obtain smaller, more homogeneous clusters than those in the initial split.
We have implemented this approach with PAM, using the average silhouette
to select the number of clusters in each split. We can order the clusters at
a given level according to the distance between their medoids. By carrying
out the algorithm until every gene is in its own cluster or by stopping at a
specified size cluster and then ordering the elements in each cluster, we obtain
a unique final ordering of the elements. With genes, for example, the first split
often shows strong evidence in favor of no more than two clusters, usually
corresponding to over- and under-expressed genes. When these two subsets
are examined separately, however, it is easy to see that the genes in each can
be clustered into smaller groups. In some applications it is also interesting to
hierarchically cluster samples. Even when one chooses to work with the first
level of the tree only, the rundown tree can still provide a useful ordering of
the elements.
We applied hierarchical PAM with a Euclidean distance metric to the ALL/AML
data set. After the initial split of the genes into two clusters (corresponding
to low and high average expression), we again clustered the genes in each of
these gene clusters in a hierarchical fashion in order to obtain a final ordering
of the genes. Figure 2 shows the ordered distance matrix. The blocks on the
diagonal are clusters of similar genes. We can indicate the cluster splits from
any level of the tree with lines. There were four clusters at level two of the tree
and ten clusters at level three of the tree (one containing just one gene). The
first split is most obvious, but it is easy to see why PAM divided the genes
as it did at both of the next two levels. We find this sort of plot useful for
deciding how many clusters there are in the data so that we can “cut” the tree
at an appropriate level and possibly recombine clusters that visually do not
look like they should have been split. This level can then be used to report
gene clusters, possibly cluster patients within gene clusters, and bootstrap the
result. Furthermore, if the clusters are strong, then they should correspond
with very bright blocks on the diagonal. In this way, we can identify the most
homogeneous clusters, which should contain genes that are part of the same
causal pathway.

6.3

Clustering Patients within Gene Clusters

Finally, we performed the composition of gene and patient clustering in the
opposite order. Using the gene clusters at any level of the hierarchical tree,
patients can be clustered within gene clusters. The lower the level of the gene
clustering tree, the more gene clusters there are to work with and hence the
genes in each of these are fewer in number and more homogeneous. Although
most clusters of genes showed little variance across patients, we found strong
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evidence of patient clustering in some of the gene clusters.
We had imagined that the ALL/AML distinction might be explained by a
single cluster of genes very differentially expressed between the two types.
While gene clusters which partition patients well exist in this data set, no
single gene cluster was able to cluster the ALL and AML patients as well as the
full set of genes. In fact, even when we used our knowledge of the ALL/AML
labels and selected the genes with largest t-statistics for the difference in means
between the two groups, the top 65 genes were needed to cluster patients as
well as the full set of genes. These genes came from several different gene
clusters and had both low and high mean expression. Perhaps a different
distance metric might have clustered these genes closer together, although
we found that they fell into different gene clusters with both Euclidean and
correlation metrics.
Although the patient clusters found in some of the small gene clusters do not
correspond directly with the ALL/AML distinction, they are nonetheless interesting findings. It seems likely to us that they might correspond with some
other clinical or pathological variables, such as tumor grade, survival, or treatment history. Using the ten gene clusters from level three, we found several
small groups of genes with very strong evidence of patient clustering. In five of
these gene clusters, we found groups of between one and four patients which
clustered separately from all the others. In each case, the unique patients were
either all ALL or all AML patients, leading us to believe that the ALL/AML
categories themselves might be quite heterogeneous with subgroups of patients
within each sharing particular mutations. In several cases, there was just one
patient with a very different profile than the others across several genes (See
Figure 3). Expression patterns such as these could be experimental errors
(e.g.: bad slide regions) or in fact evidence of a different biological state, such
as having a particular biochemical pathway activated. It would certainly be
interesting to look for correlations between the gene cluster specific patient
labels and various outcome variables.
By clustering patients within gene clusters we have found more complicated
patterns than those seen when patients are simply clustered overall. This data
set is known for the easy distinction of ALL and AML patients, and the
finer level of patient clustering illustrated here is likely to correspond to other
biological distinctions. We want to point out, however, that in other data
sets we have worked with, the identification of groups of patients has been
more complex in the sense that strong clusters were not evident overall (as
they were here), but there were in fact smaller gene clusters which clustered
patients well. Regardless of whether or not there is strong clustering of samples
overall, the identification of small groups of genes with interesting expression
patterns across samples can help researchers develop hypotheses to test in the
lab or field.
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6.4

Bootstrap Results

As we recommend, findings such as those discussed above should be qualified
by reliability measures. In order to illustrate the way in which the bootstrap
can be applied to perform inference on summary measures of a simultaneous
clustering parameter, we looked at the result from clustering genes within
patient clusters. We generated new samples using (i) nonparametric bootstrap,
(ii) convex bootstrap with d = 0.1, and (ii) parametric bootstrap based on a
mixture of two normal distributions with diagonal covariances. The empirical
values of the mixing proportion, means, and variances from the two patient
clusters in the original data were used in the parametric bootstrap.
For each bootstrap sample, the simultaneous clustering procedure was repeated: patients were clustered first, followed by genes within each patient
cluster. We performed unsupervised clustering but used the same values for
k as in the data analysis (k = 2 in each case). Since the two clusters from
each application of PAM differed significantly in size in this case, we were able
to infer a correspondence between the unsupervised clusters and the original
clusters. We kept track of the medoids associated with the “big” and “small”
clusters. These were very uniform in expression profile across bootstrap samples, particularly for gene clustering where the “small” cluster medoid always
had much higher expression. One could also keep track for each gene of the
proportion of bootstrap samples in which it appeared in each gene cluster. As
discussed in van der Laan and Bryan [18], this measure estimates the probability that a gene belongs to its cluster. We also kept track of average silhouette
and proportion of elements in the larger cluster.
Table 5 contains the results of the bootstrap analysis. The confidence intervals
for the summary measures indicate that the clustering results, particularly for
genes, were quite stable. We see some bias in the confidence intervals for summary measures of patient clustering (i.e.: they are not centered around the
point estimate from the observed data), presumably due to the small sample
size. Here, empirical confidence intervals might be better than normal distribution confidence intervals, since the central limit theorem does not appear
to be in action yet.
By simulating data from an appropriate null distribution, it is possible to
derive quantiles for summary measures under the null hypothesis that there
is no clustering. These can be used to test whether summary measures show
true evidence of clustering. We did this simulation for each clustering result
and found the 0.95 quantiles of the average silhouette from single multivariate
normals – not mixtures – with diagonal covariances and the empirical mean
and variance vectors. For patient clustering, the lower 95% confidence intervals
for the observed average silhouettes are only slightly larger than the null value,
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indicating that the clusering of patients is barely significant with this sample
size. For gene clustering within each patient cluster, however, the lower 95%
confidence intervals for the observed average silhouettes were well above the
null values, confirming that there is strong evidence of gene clustering in this
data set.

7

Discussion

We have demonstrated that a large family of two-way clustering methods can
be regarded as compositions of mappings involving clustering of genes and/or
mappings involving clustering of patients. In this way, we can define a simultaneous clustering parameter as a function of the underlying data generating
distribution that produced the results of a gene expression experiment. This
statistical formalism allows us to understand and perform both estimation
and inference using many commonly employed clustering methods. By forming iterative compositions, we can also design more aggressive algorithms for
finding patterns in data. The beauty of this framework is that statistical inference, using methods such as the bootstrap, allows us to assess the reliability
of patterns found by such “greedy” algorithms. In the context of gene expression data, where the dimension of the problem (p = number of genes) far
exceeds the sample size (n), the need for this statistical rigor is particularly
important and all to often overlooked by researchers keen to identify biological
relationships between genes clustered together.
The two-way clustering methods discussed in Tibshirani et al. [17] (e.g.: hierarchical clustering, tree structured k-means, block clustering) are examples of
commonly employed techniques which can be formally defined as simultaneous
clustering parameters. Their gene shaving methodology is a more aggressive
method with a specific goal: identification of small, homogeneous subsets of
genes which have maximal variance across patients. We agree strongly with
the rationale behind gene shaving, that different clusters of genes may cluster samples in different ways. This idea motivated us to employ PAM in a
hierarchical fashion to first cluster genes and then again to cluster patients
within gene clusters. One strength of hierarchical PAM over gene shaving is
that it will identify clusters of genes with both low and high variance across
patients. The lower variance clusters can be equally interesting biologically
and (in some cases) can in fact produce interesting patient clustering results.
We have illustrated how bootstrap methods can be used to estimate the variability of simultaneous clustering parameters. Our simulations identified several interesting points about the bootstrap. Contrary to our initial hypothesis
that the parametric bootstrap would be best able to approximate the distribution of an observed simultaneous clustering parameter θn , we found that both
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the nonparametric and the parametric bootstraps performed well as methods
for estimating variance in the context of gene and patient clustering. We were
pleased to see that for sample sizes in the range of n = 150, the bootstrap
is a valid method for estimate the variability of simultaneous clustering parameters. For a sample size as small as n = 40, however, the nonparametric
bootstrap was conservative for estimating the variance of some summary measures of θn (particularly in unsupervised patient clustering). We were surprised
to find that using convex pseudo-data was not an improvement over the nonparametric bootstrap. In light of these results and the computational ease of
nonparametric resampling, we recommend the nonparametric bootstrap for
inference with reasonable sample sizes. With sample sizes as small as n = 40,
the researcher should be aware that the nonparametric bootstrap will be more
conservative than the parametric.
The bootstrap is not only a method to estimate the distribution of an estimate, but it can also be viewed as a simulation study investigating the random
behavior of an empirical estimate of θ under some known data generating distribution. In the statistics and biostatistics literature, simulation studies from
standard parametric families are generally accepted as a way of obtaining
insight into new estimation procedures. In particular, the bootstrap assesses
how hard it is to estimate clustering parameters under a known law. Therefore, the output of the parametric bootstrap will provide valuable information
even when the bootstrap distribution is not close to the true data generating
distribution. A heavily discrete distribution such as Pn (nonparametric bootstrap) resulting in many ties may not be as insightful as a simulation from
a smooth distribution such as a mixture of multivariate normal distributions.
Furthermore, a parametric bootstrap allows for simulations from a null distribution so that testing can be performed, as illustrated for average silhouettes
in the data analysis.
Although our aim was to examine the bootstraps as methods for estimating
variance, we noted in passing that there was bias in point estimates from
bootstrap samples, particularly for summary measures which were less smooth
functions of the data generating distribution (e.g.: patient cluster means).
We also found that for some parameters, normal approximation confidence
intervals were inappropriate so that empirical quantiles should be used instead.
The analysis of gene expression data from Golub et al. [9] demonstrates that simultaneous clustering parameters identify complex patterns in gene expression
data, including genes specifically up-regulated in subtypes of acute leukemia
and clusters of genes which produce interesting patient clustering results not
seen when all genes are used. Experience with other data sets supports the
idea that simultaneous clustering provides additional insight over one-way
clustering results. We have seen that even when the goal is to cluster samples, first clustering genes and then samples within gene clusters can help to
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identify important relationships amongst samples that correspond with distinct biological states and to highlight genes which are members of a single
biochemical/causal pathway. Pictures of the data matrix and particularly the
distance matrix emphasize that these insights are of real interest, since simultaneous clustering labels correspond well with visual patterns seen in the data.
Applying the bootstrap helps to understand the reliability of these patterns.
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Fig. 1. Results of simultaneous clustering of patients and then genes within patient
clusters 1 (1a-c) and 2 (2a-c). Lines mark the division between gene clusters. Plots
1a and 2a show the reordered data matrices. Each intensity is represented by a color
on the green-red scale with bright green corresponding to the lowest expression and
bright red to the highest. Plots 1b and 2b show the reordered distance matrices for
all genes based on the patients in that patient cluster. Green corresponds to the
lowest distance (i.e.: most similar genes) and red to the highest distance. Plots 1c
and 2c show the upper right hand corners of the distance matrices in more detail.
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Fig. 2. Results of hierarchical PAM on genes. (a) The reordered distance matrix
is plotted with the cluster boundaries from the second level of the tree (four gene
clusters). (b) A more detailed view of the upper right hand corner of the distance
matrix, containing all genes assigned to cluster 2 in the first level of the tree (the
high expression group). The solid lines are the cluster boundaries from the second
level of the tree (as in (a)). The dotted lines are the additional cluster boundaries
added in the third level of the tree. The gene labeled 1977 is in a cluster by itself
in the third level. The stronger the similarity between the genes in a cluster, the
more solid that cluster will appear. The last cluster (genes labeled 1985-2000), for
example, is a very solid block on the diagonal. The intensities of these genes are
consistently very high across patients and could be interesting drug targets. In both
plots, green corresponds to the lowest distance (i.e.: similar genes) and red to the
highest.
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Fig. 3. Example of the data matrix for a gene cluster with strong evidence of patient
clustering. Each intensity is represented by a color on the green-red scale with bright
green corresponding to the lowest expression and bright red to the highest. The
patients have been reordered using only the genes in this cluster. In this case, one
patient has a very different expression pattern from the others. The fact that this
patient is not expressing these genes at the high levels seen in all the other patients
could be correlated with some clinical or pathological variable. It is also interesting
to note how similar the genes are to each other. This cluster is the first from the
left in Figure 2b.
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0.9 quantile of maximum absolute difference
Parameter:

Mean

Median

Correlation

True distribution

0.60

0.74

0.75

Nonparametric

0.60

0.98

0.89

Convex d=0.1

0.59

0.97

0.89

Convex d=0.3

0.54

0.86

0.88

Convex d=0.5

0.50

0.78

0.87

Parametric

0.63

0.93

0.84

True distribution

0.25

0.30

0.35

Nonparametric

0.26

0.38

0.36

Convex d=0.1

0.23

0.34

0.36

Convex d=0.3

0.21

0.30

0.36

Convex d=0.5

0.20

0.27

0.36

Parametric

0.24

0.36

0.35

n=40

n=250

Table 1
Results of Simulation 1 for gene clustering. B = 100 i.i.d. bootstrap samples were
used in each simulation. Every bootstrap sample included n = 40 or n = 250
observations of a 3000-dimensional gene expression vector. The 0.9 quantile of the
maximum absolute difference in each summary measure is reported.
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0.9 quantile of maximum absolute difference
Parameter:

0.95 CI,

√

nσ̂

Mean 1

Mean 2

q̂

True distribution

1.31

0.79

{0.16,0.44}, 0.45

Nonparametric

1.21

0.87

{0.22,0.49}, 0.44

Convex d=0.1

1.19

0.83

{0.21,0.48}, 0.43

Convex d=0.3

1.05

0.79

{0.22,0.50}, 0.45

Convex d=0.5

0.99

0.68

{0.20,0.49}, 0.46

Parametric

1.41

0.94

{0.20,0.49}, 0.46

True distribution

0.50

0.32

{0.25,0.36}, 0.45

Nonparametric

0.51

0.32

{0.24,0.34}, 0.41

Convex d=0.1

0.47

0.29

{0.24,0.35}, 0.46

Convex d=0.3

0.43

0.26

{0.25,0.35}, 0.40

Convex d=0.5

0.42

0.26

{0.24,0.36}, 0.47

Parametric

0.52

0.33

{0.25,0.33}, 0.43

True distribution

0.38

0.25

{0.25,0.41}, 0.49

Nonparametric

0.51

0.26

{0.25,0.40}, 0.46

Convex d=0.1

0.36

0.27

{0.24,0.39}, 0.46

Convex d=0.3

0.33

0.24

{0.23,0.37}, 0.44

Convex d=0.5

0.32

0.20

{0.23,0.36}, 0.41

n=40, p=3000

n=250, p=3000

n=150, p=12

Parametric
0.37
0.28
{0.28,0.44}, 0.49
Table 2
Results of Simulation 2 for supervised clustering of patients. B = 100 i.i.d. bootstrap samples were used in each simulation. Every bootstrap sample included n = 40
or n = 250 observations of a 3000-dimensional gene expression vector or n = 150
observations of a 12-dimensional gene expression vector. The 0.9 quantile of the
maximum absolute difference in each cluster’s mean vector is reported. 95% confidence intervals for the proportion of patients in the first cluster were calculated
√
using a normal approximation. We also report n times the estimated standard
error of q̂ from each bootstrap sample.
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0.95 CI,
Parameter:

√

nσ̂

Dist. Between Medoids

Diam. Smaller Clust.

Avg. Silhouette

True dist.

{85.70,89.12}, 5.51

{78.64,80.55}, 3.07

{0.12,0.13}, 0.012

Nonparametric

{83.22,92.36}, 14.75

{75.67,83.82}, 13.15

{0.12,0.21}, 0.13

Convex d=0.1

{75.52,86.86}, 18.30

{50.61,100.11,83.82}, 79.86

{0.12,0.20}, 0.14

Convex d=0.3

{61.62,79.04}, 28.11

{33.02,106.67}, 118.82

{0.076,0.19}, 0.19

Convex d=0.5

{53.62,74.26}, 33.29

{41.72,100.03}, 94.06

{0.049,0.17}, 0.19

Parametric

{86.96,91.06}, 6.62

{78.76,80.95}, 3.50

{0.14,0.15}, 0.012

True dist.

{84.79,88.76}, 16.02

{80.37,81.43}, 4.31

{0.126,0.128}, 0.010

Nonparametric

{85.85,89.91}, 16.34

{79.91,80.77}, 3.47

{0.13,0.14}, 0.017

Convex d=0.1

{76.84,83.70}, 27.69

{78.06,79.79}, 6.96

{0.13,0.14}, 0.023

Convex d=0.3

{62.49,77.71}, 61.36

{76.32,80.48}, 16.76

{0.13,0.14}, 0.080

Convex d=0.5

{54.26,74.00}, 79.60

{75.87,79.89}, 16.22

{0.075,0.13}, 0.20

Parametric

{84.69,88.88}, 16.90

{80.27,81.49}, 4.92

{0.130,0.132}, 0.0084

True dist.

{3.57,3.77}, 5.94

{7.55,9.32}, 5.54

{0.033,0.15}, 0.35

Nonparametric

{3.05,5.06}, 6.29

{7.35,9.09}, 5.42

{0.066,0.14}, 0.22

Convex d=0.1

{3.03,4.70}, 5.22

{6.97,8.79}, 5.67

{0.064,0.14}, 0.22

Convex d=0.3

{2.34,4.05}, 5.33

{6.47,8.44}, 6.16

{0.048,0.13}, 0.25

Convex d=0.5

{2.04,3.78}, 5.42

{6.19,7.93}, 5.44

{0.047,0.13}, 0.26

n=40, p=3000

n=250, p=3000

n=150, p=12

Parametric
{2.67,4.66}, 6.23
{7.70,9.27}, 4.89
{0.045,0.13}, 0.26
Table 3
Results of Simulation 2 for unsupervised clustering of patients. B = 100 i.i.d. bootstrap samples were used in each simulation. Every bootstrap sample included n = 40
or n = 250 observations of a 3000-dimensional gene expression vector. The normal
approximation 95% confidence interval for each summary measure is reported. We
√
also report n times the estimated standard error of the summary measures from
each bootstrap sample. Three significant figures are reported where needed to see
the width of very narrow confidence intervals.
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ALL

AML

Cluster 1

25

1

26

Cluster 2

2

10

12

27
11
38
Table 4
Clustering of patients using PAM with a Euclidean distance metric. The correspondence between the clustering labels and the ALL/AML labels is strong.
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0.95 CI,

√

nσ̂

Patients

Genes 1

Genes 2

Observed Data

0.6842

0.9740

0.9760

Nonparametric

{0.53,0.99},0.72

{0.327,0.332},0.0084

{0.32,0.33},0.018

Convex d=0.1

{0.57,0.95},0.60

{0.32,0.33},0.0077

{0.32,0.33},0.013

{0.0.58,0.89},0.48

{0.327,0.331},0.0077

{0.32,0.34},0.022

Null 0.95 quantile

0.0224

0.0355

0.0851

Observed Data

0.1037

0.9189

0.9213

Nonparametric

{0.061,0.36},0.47

{0.91,0.94},0.050

{0.90,0.95},0.078

Convex d=0.1

{0.046,0.33},0.45

{0.91,0.94},0.051

{0.91,0.94},0.060

Prop. in larger cluster q̂:

Parametric
Silhouettes:

Parametric
{0.11,0.21},0.16
{0.91,0.93},0.024
{0.89,0.95},0.11
Table 5
Results of unsupervised bootstrap on ALL/AML data set (n = 38, p = 2000).
B = 100 bootstrap samples were used to estimate normal approximation 95% confi√
dence intervals for each summary measure. We also report n times the estimated
standard error of the summary measures from each bootstrap sample. Genes 1 and
Genes 2 refer to results from clustering genes within patient clusters 1 and 2, respectively. The null 0.95 quantiles of the average silhouettes were computed from
simulations with B = 100 samples drawn from null distributions. Three significant figures are reported where needed to see the width of very narrow confidence
intervals.
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